Logo image of AHR

AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis

NYSE:AHR - New York Stock Exchange, Inc. - US3981823038 - REIT - Currency: USD

36.65  +0.44 (+1.22%)

After market: 36.65 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AHR. AHR was compared to 130 industry peers in the Diversified REITs industry. AHR may be in some trouble as it scores bad on both profitability and health. AHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AHR had negative earnings in the past year.
AHR had a positive operating cash flow in the past year.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

AHR has a worse Return On Assets (-0.91%) than 67.44% of its industry peers.
Looking at the Return On Equity, with a value of -1.80%, AHR is doing worse than 63.57% of the companies in the same industry.
With a Return On Invested Capital value of 2.92%, AHR perfoms like the industry average, outperforming 58.14% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AHR is in line with the industry average of 3.16%.
The 3 year average ROIC (1.94%) for AHR is below the current ROIC(2.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.91%
ROE -1.8%
ROIC 2.92%
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

With a Operating Margin value of 7.08%, AHR is not doing good in the industry: 82.95% of the companies in the same industry are doing better.
AHR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 20.32%, AHR is doing worse than 92.25% of the companies in the same industry.
AHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.08%
PM (TTM) N/A
GM 20.32%
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

AHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AHR has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AHR has an improved debt to assets ratio.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that AHR is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.67, AHR belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
The Debt to FCF ratio of AHR is 22.99, which is on the high side as it means it would take AHR, 22.99 years of fcf income to pay off all of its debts.
AHR has a better Debt to FCF ratio (22.99) than 76.74% of its industry peers.
AHR has a Debt/Equity ratio of 0.74. This is a neutral value indicating AHR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, AHR is in the better half of the industry, outperforming 73.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 22.99
Altman-Z 1.67
ROIC/WACC0.38
WACC7.79%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.72 indicates that AHR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, AHR is doing worse than 64.34% of the companies in the same industry.
AHR has a Quick Ratio of 0.72. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.72, AHR is not doing good in the industry: 62.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

AHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.48%, which is quite impressive.
AHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.34%.
Measured over the past years, AHR shows a quite strong growth in Revenue. The Revenue has been growing by 17.32% on average per year.
EPS 1Y (TTM)63.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
Revenue 1Y (TTM)10.34%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%8.22%

3.2 Future

The Earnings Per Share is expected to grow by 76.69% on average over the next years. This is a very strong growth
AHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.05% yearly.
EPS Next Y234.67%
EPS Next 2Y111.4%
EPS Next 3Y76.69%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y7.76%
Revenue Next 3Y8.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AHR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 54.98, the valuation of AHR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as AHR.
AHR is valuated expensively when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 54.98
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

AHR's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AHR is more expensive than 90.70% of the companies in the same industry.
AHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 80.1
EV/EBITDA 22.74
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AHR's earnings are expected to grow with 76.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y111.4%
EPS Next 3Y76.69%

More info and screens

1

5. Dividend

5.1 Amount

AHR has a Yearly Dividend Yield of 2.76%.
Compared to an average industry Dividend Yield of 6.44, AHR's dividend is way lower than its industry peers. On top of this 82.95% of the companies listed in the same industry pay a better dividend than AHR!
Compared to an average S&P500 Dividend Yield of 2.35, AHR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.76%

5.2 History

AHR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

AHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-353.22%
EPS Next 2Y111.4%
EPS Next 3Y76.69%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 50M -50M 100M -100M

More info and screens

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (7/11/2025, 8:04:00 PM)

After market: 36.65 0 (0%)

36.65

+0.44 (+1.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07
Inst Owners97.91%
Inst Owner Change0%
Ins Owners0.85%
Ins Owner Change8.04%
Market Cap5.85B
Analysts82.86
Price Target40.8 (11.32%)
Short Float %2.88%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 2.76%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-353.22%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-30 2025-06-30 (0.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-144.27%
Min EPS beat(2)-359.9%
Max EPS beat(2)71.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)1.21%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)6.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.57%
PT rev (3m)18.08%
EPS NQ rev (1m)6.12%
EPS NQ rev (3m)15.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.56%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 54.98
P/S 2.77
P/FCF 80.1
P/OCF 24.09
P/B 2.58
P/tB 3.12
EV/EBITDA 22.74
EPS(TTM)-0.14
EYN/A
EPS(NY)0.67
Fwd EY1.82%
FCF(TTM)0.46
FCFY1.25%
OCF(TTM)1.52
OCFY4.15%
SpS13.24
BVpS14.18
TBVpS11.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.91%
ROE -1.8%
ROCE 3.7%
ROIC 2.92%
ROICexc 2.99%
ROICexgc 3.35%
OM 7.08%
PM (TTM) N/A
GM 20.32%
FCFM 3.46%
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexcg growth 3Y56.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 22.99
Debt/EBITDA 5.13
Cap/Depr 95.57%
Cap/Sales 8.03%
Interest Coverage 1.47
Cash Conversion 74.2%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 1.67
F-Score7
WACC7.79%
ROIC/WACC0.38
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
EPS Next Y234.67%
EPS Next 2Y111.4%
EPS Next 3Y76.69%
EPS Next 5YN/A
Revenue 1Y (TTM)10.34%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%8.22%
Revenue Next Year8.81%
Revenue Next 2Y7.76%
Revenue Next 3Y8.05%
Revenue Next 5YN/A
EBIT growth 1Y57.11%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year163.11%
EBIT Next 3Y45.97%
EBIT Next 5YN/A
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A